Trial intelligence / Profile preview

Multicenter open-label phase IV study of Binglian Qingyan spray in acute pharyngitis and acute exacerbation of chronic pharyngitis

CTR20160296Phase 4Completed

Sponsor
Hunan Sanjiu Nankai Pharmaceutical
Start
May 2016
Countries
1
01

Overview

A Phase 4 trial of Binglian Qingyan in acute pharyngitis, pharyngitis, sponsored by Hunan Sanjiu Nankai Pharmaceutical. Started May 2016; status: completed.

02

Drugs

Binglian Qingyan
03

Conditions

acute pharyngitispharyngitis

Beyond the preview

Go deeper on CTR20160296.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20160296.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call